Ready-to-use combo vaccines protect against PCV2 and Lawsonia while maintaining Mycoplasma-negative status – simplifying ...
The evolving treatment landscape in polycythemia vera (PV) is shifting from a focus on hematocrit control to a more ...
Opportunity 180 CEO Tamara Shear said the money will go toward helping proven charter school leaders expand their reach in ...